Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
Dr. Philip Claessens - Cardiologie from Schilde, company number BE0899711523, closed financial year 2025 with a result of € 453,845 after tax. For that financial year Dr. Philip Claessens - Cardiologie recorded a gross margin of € 830,310 and equity of € 2.3 million. Compared with financial year 2024, the result moved from € 451,236 to € 453,845. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 30, 2025.
€ 2.3 million
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 453,845
▲ 1% vs 2024
Profit after tax over the fiscal year.
€ 662,271
▲ 12% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 450,000 paid out
99 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
1.7
▼ 0.5 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 91,787
▼ 11% vs 2024
€ 54,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 2,206
▼ 45% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 916,309
▼ 10% vs 2024
€ 105,051 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.
€ 28,666
▲ 252% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 74,188
▲ 5% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 653,687 | € 873,510 | € 833,091 | € 830,310 | |
| Profit after taxes | € 312,101 | € 474,142 | € 451,236 | € 453,845 | ▲ 1% |
| Equity | € 1,654,774 | € 2,021,916 | € 2,253,152 | € 2,256,997 | |
| Total debts | € 1,258,874 | € 1,211,889 | € 1,102,366 | € 1,019,857 | ▼ 7% |
| Cash | € 295,557 | € 458,202 | € 588,851 | € 662,271 | ▲ 12% |
| Land & buildings | € 1,500,124 | € 1,422,316 | € 1,351,420 | € 1,356,134 | |
| Retained profit | € 1,623,374 | € 1,990,516 | € 2,221,752 | € 2,225,597 | |
| Dividend | € 78,000 | € 107,000 | € 220,000 | € 450,000 | ▲ 105% |
| Bank debt | € 1,170,757 | € 1,082,178 | € 1,019,075 | € 916,309 | ▼ 10% |
| Balance sheet total | € 2,913,648 | € 3,233,805 | € 3,355,518 | € 3,276,854 | ▼ 2% |
| Employees (FTE) | 1.7 | 1.9 | 2.2 | 1.7 | ▼ 0.5 |
Key figures of Dr. Philip Claessens - Cardiologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 October 2026.
What happened to Dr. Philip Claessens - Cardiologie?
What happened at Dr. Philip Claessens - Cardiologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 453,845 (▲ 1% vs 2024). Source: NBB ↗
- Hilde Bloemen became a director. NBB
- Philip Claessens became a director. NBB
- New establishment in Essen. KBO
- New establishment in Schilde. KBO
- Start of the company according to the CBE. KBO
In short
From € 312,101 profit in 2022 to € 453,845 profit in 2025.
Paid € 787,579 in corporate taxes since 2022.
Best year ever: 2023, with € 474,142 profit.
On average € 488,400 of value added per employee in 2025.
A new publication or filing at Dr. Philip Claessens - Cardiologie? We notify you, reason included.
Follow Dr. Philip Claessens - CardiologieDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Dr. Philip Claessens - Cardiologie are Hilde Bloemen and Philip Claessens. The same people are also behind B-Praxis.
Establishments
Establishment units
Physical locations of this company
Turnhoutsebaan 39
2970 Schilde
Turnhoutsebaan 170
2970 Schilde
Active since 8 August 2008
Stationsstraat 44
2910 Essen
Active since 17 March 2014
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0899.711.523
- VAT number
- BE 0899.711.523
- Registered office
- Turnhoutsebaan 39, 2970 Schilde
- Names & denominations
- Dr. Philip Claessens - Cardiologie
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 6 August 2008
- Peppol
- Not registered
- Activities · NACE
Activiteiten van medisch specialisten